This article is more than 5 years old. Information may no longer be current.

Abrams Royal Compounding Pharmacy initiates voluntary recall of drugs

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Non-expired drug products produced and distributed for sterile use by Abrams Royal Compounding Pharmacy in Dallas are being voluntarily recalled, according to a press release from the U.S. Food and Drug Administration.

Injectable medications, intravenous injections, eye drops, pellet implants, nasal sprays, inhalation solutions and eye ointments are included in the recall and were distributed between June 17, 2013, and Dec. 17, 2013, according to the release.

Health care professionals who have these products should stop using them. Abrams has started notifying customers by mail and is arranging for the return of all recalled medication. Users can contact Abrams Royal at 214-349-8000.

The FDA is aware of one adverse event associated with a mineral IV injection with the lot number 11142013@74. A patient who received this product was admitted to a hospital and had blood cultures that tested positive for Stenotrophomonas maltophilia, according to the release.

Adverse reactions should be reported to the FDA’s MedWatch adverse event reporting program at www.fda.gov/medwatch/report.htm.